Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Valeant Re-Appoints Board Member

This article was originally published in Scrip

Executive Summary

Valeant Pharmaceuticals International Plc. has reappointed Mason Morfit to its board of directors – effective immediately. Morfit originally served on the board from 2007 to 2014 and is currently president of ValueAct Capital, a governance-orientated investment fund. He is also on the board for Microsoft Corp. and is a former director of CR Bard Inc., Immucor Inc., Advanced Medical Optics, Solexa Inc., and MSD Performance, Inc.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts